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Abstract In order to test the possibility that free fatty acids are 
the mediator of the abnormal expression of urea cycle enzyme 
genes in carnitine-deficient juvenile visceral steatosis (JVS) mice, 
the effects of fatty acids on urea cycle enzyme, carbamoylphos- 
phate synthetase (CPS) and argininosuccinate synthetase 
(ASS), mRNA levels were examined in rat primary cultured 
hepatocytes. Addition of a synthetic glucocorticoid hormone, 
dexamethasone, caused increases in CPS and ASS mRNAs. 
Further addition of oleic acid suppressed the induction of CPS 
and ASS mRNAs by dexamethasone. In contrast, the phospho- 
enolpyruvate carhoxykinase (PEPCK) mRNA level induced by 
dexamethasone was enhanced in the presence of oleic acid. The 
effects were reversed on further addition of carnitine. The mRNA 
levels of these enzymes induced by dibutyryl cAMP were not 
affected by the addition of oleic acid. A study of the specificity of 
fatty acids revealed that long-chain fatty acids of more than 16 
carbons chain length had a suppressive ffect on the CPS mRNA 
level induced by dexamethasone and that the presence of double 
bonds enhanced the effect. The changes in gene expression of 
CPS, ASS and PEPCK caused by the fatty acids in the cultured 
hepatocytes were very similar to those observed in the liver of 
JVS mice. The AP-1 DNA binding activity in the presence of 
dexamethasone was slightly enhanced by the addition of oleic 
acid. These results suggest that the long-chain fatty acids not 
metabolized in JVS mice are mediators of the abnormal gene 
expression in the liver which results in hyperammonemia. 
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1. Introduction 
Fatty acids are normal metabolites with serum concentra- 
tion of about 1 mM. They are metabolized to fatty acyl-CoA 
in the cells, and further to acetyl-CoA by [3-oxidation, to 
triacylglycerol or to phospholipid. The degradative metabo- 
lism of long-chain fatty acids by [3-oxidation eeds carnitine 
as a cofactor for transport into the mitochondria. In heredi- 
tary carnitine-deficient JVS mice, the major symptoms in the 
infantile period are fatty liver, hypoglycaemia and hyperam- 
monemia [1,2]. We have shown that the hyperammonemia is 
caused by the suppression of urea cycle enzyme genes [3-5], 
which is effectively treated by the administration of carnitine 
[6] and may be related to enhanced c-jun and c-fos expression 
and AP-1 DNA binding activity [5,7]. The concentration of 
free fatty acid in serum is very high in infant JVS mice and in 
starved adult JVS mice where the induction of the urea cycle 
enzyme genes is suppressed [8]. 
We postulate that fatty acid is a mediator causing the sup- 
pression of gene expression of urea cycle enzymes in carnitine 
deficiency. In the present paper, we examine the effect of fatty 
acids on the mRNA levels of carbamoylphosphate Synthetase 
(CPS; EC 2.7.2.5) and argininosuccinate synthetase (ASS; EC 
6.3.4.5) induced by a synthetic glucocorticoid hormone, dex- 
amethasone, in rat primary hepatocytes. 
2. Materials and methods 
2.1. Primary culture of rat hepatocytes 
Parenchymal hepatocytes were isolated from male Wistar rats 
weighing 180 300 g by in situ perfusion of the liver with collagenase 
[9]. Cells at a density of 2× 106 cells per 60 mm dish were cultured 
with Williams E (WE) medium containing 10% calf serum and 1 nM 
insulin. After 4-6 h of culture, the medium was replaced by fresh WE 
medium containing 5% calf serum. Before treatments, cells were cul- 
tured in serum-free WE medium containing 0.33%0 fatty acid-free bo- 
vine serum albumin for 8 h. Treatment started 24 h after plating in 
serum-free WE medium. Hepatocytes were exposed to various treat- 
ments for 3 24 h, as indicated in the text and figure legends. Control 
cells were exposed to 0.33% bovine serum albumin in WE medium. 
Dexamethasone and fatty acids were dissolved in ethanol, and clofi- 
brate and 12-O-tetradecanoylphorbol 13-acetate (TPA) in dimethyl- 
sulfoxide. The viability of all cell preparations was greater than 85% 
as estimated by the trypan blue exclusion assay. Cytotoxicity was 
determined by assaying the release of lactate dehydrogenase into the 
medium using the method of Cabaud and Wroblewski [10]. No sig- 
nificant increase of the enzyme released into the medium was ob- 
served. 
2.2. Isolation and analysis of RNA 
Total cellular RNA from the cultured hepatocytes 24 h after treat- 
ments was isolated according to Chomczynski and Sacchi [11] and 
used for analyses of mRNAs for CPS, ASS, phosphoenolpyruvate 
carboxykinase (PEPCK; EC 6.4.1.1), tyrosine aminotransferase (EC 
2.6.1.5) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 
EC 1.2.1.12) by Northern and slot-blot hybridization with specific 
cDNA probes [4]. 
2.3. Gel mobility-shift assay 
Nuclear extracts from cultured hepatocytes were prepared as de- 
scribed by Schreiber et al. [12]. Double-stranded synthetic oligonu- 
cleotides were labeled with [T-a2P]ATP and T4 polynucleotide kinase, 
and used as probes. The binding reaction was carried out as described 
by Murakami et al. [13]. 
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3. Results and discussion 
We examined the effect of oleic acid on CPS, ASS, PEPCK 
and GAPDH mRNAs in primary cultured hepatocytes with 
and without dexamethasone and dibutyryl cAMP (Fig. 1). 
Addition of 0.5 mM oleic acid (OA) to the medium caused 
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ahnost no changes in the amounts of mRNA. Addition of 10 
nM dexamethasone (Dex) led to approx. 30-, 5- and 2-fold 
increases in CPS, ASS and PEPCK mRNAs, respectively. 
Further addition of oleic acid (Dex+OA) suppressed the in- 
duction of CPS and ASS mRNAs by dexamethasone, and 
enhanced that of PEPCK mRNA. The presence of 1 mM 
c~:rnitine in the system (Dex+OA+Cn) relieved the suppres- 
si m and enhancement by oleic acid of CPS and ASS induc- 
ti, >n and of PEPCK induction, respectively. Oleic acid showed 
n,~ effect on the induction of CPS, ASS and PEPCK by 10 gM 
d~ butyryl cAMP. In the case of GAPDH, dexamethasone and 
d~butyryl cAMP resulted in a slight decrease and increase in 
tl~e mRNA content, respectively, and oleic acid caused a slight 
i~ crease in the content irrespective of dexamethasone and di- 
b~tyryl cAMP. Tyrosine aminotransferase mRNA was 
cltanged like CPS and ASS mRNAs (data not shown). 
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t'ig. 1. Effect of oleic acid (OA) and carnitine (Cn) on induction by 
~ examethasone (Dex) and dibutyryl cAMP (cAMP) of carbamoyl- 
phosphate synthetase (CPS), argininosuccinate synthetase (ASS), 
l,hosphoenolpyruvate c rboxykinase (PEPCK) and glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) mRNAs in cultured hepato- 
, ytes. (A) Total RNA (20 gg/lane) isolated from cultured hepato- 
, ytes was analyzed by Northern blot hybridization as described un- 
der Section 2. (B) mRNA contents were quantitated by slot-blot 
hybridization analysis and values are presented as means+S.D, in
relative absorbance with dexamethasone as 100. Experimental details 
~re given in Section 2. Concentrations of reagents used were 0.5 
mM oleic acid, 10 nM dexamethasone, 1 mM carnitine, and 10 gM 
dibutyryl cAMP. Statistically significant differences between the 
groups with and without oleic acid or carnitine: *P<0.05 and 
*P<0.01. 
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Fig. 2. Effect of various fatty acids, TPA, clofibrate and carnitine 
on induction by dexamethasone of CPS mRNA in the cultured he- 
patocytes. Fatty acids indicated with numbers of carbons and dou- 
ble bonds, TPA or clofibrate were added to the medium with 10 
nM dexamethasone at the concentration i dicated without (-) or 
with (+) 1 mM carnitine. Values are presented as means +_ S.D. 
Numbers in columns denote numbers of experiments. Statistically 
significant differences from the value of dexamethasone only (n = 8; 
100 + _ 11.7): *P<0.05 and **P<0.01. 
cocorticoid of a group of genes. These changes in the mRNA 
of the enzymes caused by oleic acid seem to mimic those in 
the liver of JVS mice [4,14]. Increase in the oleic acid concen- 
tration dose-dependently increased the suppressive effect on 
dexamethasone i duction of CPS mRNA, with 0.5 mM oleic 
acid reducing induction to about 50% (Fig. 2). 
Furthermore, we assessed the specificity of fatty acids, as 
shown in Fig. 2. The induction of CPS mRNA by dexametha- 
sone was not influenced by the addition of saturated medium- 
chain fatty acids (carbon-chain length less than 14). Saturated 
fatty acids having a carbon-chain length greater than 16 dem- 
onstrated suppressive ffects and the presence of double 
bonds enhanced the suppressive ffect. Myristic acid (14:0) 
displayed no influence but myristoleic acid (14:1) showed a 
strong effect. Arachidonic acid (20:4) was the strongest sup- 
pressor we tested. With all fatty acids, addition of 1 mM 
carnitine reversed the effect almost completely. This suggests 
that the effect of fatty acids results partly from a shortage of 
carnitine in primary cultured hepatocytes [15] causing the ac- 
cumulation of fatty acids and that the addition of carnitine 
stimulates the metabolism by converting the fatty acids into 
fatty acylcarnitine. Addition of 0.5 mM lauric acid (12:0) or 
salicylic acid, which were not effective but may compete with 
an effective fatty acid for CoA to be further metabolized, id 
not have any effect on the suppression (data not shown). All 
these results suggest hat the mediators are free fatty acids, 
but not their metabolites. The spectrum of fatty acids affecting 
the induction by dexamethasone seems to be similar to that 
for protein kinase C activation. Unsaturated long-chain fatty 
acids such as oleic acid and arachidonic acid have been re- 
ported to activate protein kinase C [16,17]. TPA (0.2 I.tM), a 
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Fig. 3. Effect of oleic acid (OA) on AP-I and Sp-1 DNA binding 
activities in the nuclear extract of cultured hepatocytes in the pres- 
ence and absence of dexamethasone (D x) and carnitine (Cn). Nu- 
clear extract was prepared from hepatocytes cultured for 12 and 
24 h after the additions indicated. Concentrations of reagents used 
were 10 nM dexamethasone, 0.5 mM oleic acid, and 1 mM carni- 
tine. 
potent protein kinase C activator, suppressed induction of 
CPS mRNA by dexamethasone (Fig. 2). We do not have 
conclusive data on this mechanism, because protein kinase 
C inhibitors howed no consistent results (data not shown) 
and as shown in Fig. 2, suppression was caused by saturated 
long-chain fatty acids such as palmitic acid and stearic acid 
which were reported not to activate protein kinase C [16,17]. 
Addition of clofibrate, a peroxisome proliferator, had no ef- 
fect on the induction of CPS mRNA. 
Finally, we assayed the AP-1 DNA binding activity by gel 
shift analysis of the nuclear fractions from the cultured hepa- 
tocytes under the conditions described in Fig. 3, since AP-1 
DNA binding was highly activated in the liver of JVS mice [7]. 
AP-I DNA binding activity observed under basal conditions 
was reduced by the addition of dexamethasone (Dex). Addi- 
tion of oleic acid with dexamethasone (Dex+OA) enhanced 
the activity at 12 h but the effect was not clear at 24 h. 
Further addition of carnitine (Dex+OA+Cn) reduced the ef- 
fect of oleic acid partially at 3 h (data not shown) and com- 
pletely to the level of dexamethasone (Dex) at 12 h. Oleic acid 
only (OA) caused almost no change in the DNA binding 
activity. Sp-1 DNA binding activity was not affected by these 
treatments. These results suggest that the activated AP-I 
DNA binding activity may enhance or mediate suppression 
of urea cycle enzyme genes by fatty acids in cultured hepato- 
cytes, although the AP-1 DNA binding activity was not as 
markedly activated as found in JVS mice in vivo. The cross 
coupling between glucocorticoid receptor and AP-1, suggested 
by Yang-Yen et al. [18] and Schfile and Evans [19,20], may be 
a possible mechanism for the suppression of the glucocorti- 
coid-responsive gene expression. The results showing en- 
hanced glucocorticoid induction of PEPCK by fatty acids, 
however, cannot be explained by the cross coupling between 
glucocorticoid receptor and AP-1. Further analyses are under 
way to elucidate the mechanism of the fatty acid effect on 
gene expression and to examine its connection with the patho- 
physiology of JVS mice in vivo. 
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